Swine and Avian Influenza Drug Development Pipeline Review, 2017
This report provides an overview of the Swine and Avian Influenza pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for influenza A virus, subtypes H5N1 and H1N1, and features dormant and discontinued projects.
H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. There are a total of 63 products in development for this indication, by 47 companies and six academic institutions.
H1N1 Infection also called as swine flu is a new kind of flu in humans. Its caused by the contagious H1N1 influenza virus. There are a total of 99 products in development for this indication, by 67 companies and 14 academic institutions.
In both types of influenza, the most common molecular target being studied is hemagglutinin, by a considerable margin. However, a number of both human and viral proteins are also under active development.
- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
- Understand the overall pipeline, with an ataglance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an uptodate overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Swine and Avian Influenza Report Coverage 8
2.2 Influenza A Virus, H5N1 Subtype Infections – Overview 8
2.3 Influenza A Virus, H1N1 Subtype Infections – Overview 8
3 Therapeutics Development 9
3.1 Influenza A Virus, H5N1 Subtype Infections 9
3.2 Influenza A Virus, H1N1 Subtype Infections 18
4 Therapeutics Assessment 30
4.1 Influenza A Virus, H5N1 Subtype Infections 30
4.2 Influenza A Virus, H1N1 Subtype Infections 36
5 Companies Involved in Therapeutics Development 43
5.1 Influenza A Virus, H5N1 Subtype Infections 43
5.2 Influenza A Virus, H1N1 Subtype Infections 58
6 Dormant Projects 81
6.1 Influenza A Virus, H5N1 Subtype Infections 81
6.2 Influenza A Virus, H1N1 Subtype Infections 86
7 Discontinued Products 90
7.1 Influenza A Virus, H5N1 Subtype Infections 90
7.2 Influenza A Virus, H1N1 Subtype Infections 90
8 Product Development Milestones 91
8.1 Influenza A Virus, H5N1 Subtype Infections 91
8.2 Influenza A Virus, H1N1 Subtype Infections 103
9 Appendix 118
9.1 Methodology 118
9.2 Coverage 118
9.3 Secondary Research 118
9.4 Primary Research 118
9.5 Expert Panel Validation 118
9.6 Contact Us 119
9.7 Disclaimer 119
New York City Zone 01,
NY, United States.
International: (+1) 646 781 7170
UK (Toll free): +44 800 088 5734
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
24MarketReports is the marque of market research industry which identifies massive database of market research reports. We are having a numerous sectors market research gathering which covers diverse verticals around the Earth. Our central focus to make it trouble-free for decision makers to find applicable information and locate right Research reports which can save their time and assist in what they do best.